このページの翻訳は実験的なもので、現在開発中です。お待ちしております！
HLS Therapeutics マネジメント
マネジメント 基準チェック /14
HLS Therapeutics'の CEO はCraig Millianで、 May2023年に任命され、 の在任期間は 1.08年です。 の年間総報酬は$ 1.41Mで、 26.9%給与と73.1%のボーナス（会社の株式とオプションを含む）で構成されています。 は、会社の株式の0.039%を直接所有しており、その価値はCA$ 41.25K 。経営陣と取締役会の平均在任期間はそれぞれ3.6年と2.3年です。
主要情報
Craig Millian
最高経営責任者
US$1.4m
報酬総額
| CEO給与比率 | 26.9% |
| CEO在任期間 | 1.1yrs |
| CEOの所有権 | 0.04% |
| 経営陣の平均在職期間 | 3.6yrs |
| 取締役会の平均在任期間 | 2.3yrs |
経営陣の近況
Recent updates
Analysts Have Lowered Expectations For HLS Therapeutics Inc. (TSE:HLS) After Its Latest Results
May 12
After Leaping 29% HLS Therapeutics Inc. (TSE:HLS) Shares Are Not Flying Under The Radar
Apr 14Here's Why HLS Therapeutics (TSE:HLS) Can Afford Some Debt
Apr 06Analysts Are More Bearish On HLS Therapeutics Inc. (TSE:HLS) Than They Used To Be
Nov 16Here's Why HLS Therapeutics (TSE:HLS) Can Afford Some Debt
Sep 13Would HLS Therapeutics (TSE:HLS) Be Better Off With Less Debt?
May 05HLS Therapeutics (TSE:HLS) Is Due To Pay A Dividend Of $0.05
Apr 05HLS Therapeutics (TSE:HLS) Is Paying Out A Dividend Of $0.05
Mar 20HLS Therapeutics (TSE:HLS) Has Affirmed Its Dividend Of $0.05
Nov 30Downgrade: Here's How Analysts See HLS Therapeutics Inc. (TSE:HLS) Performing In The Near Term
Nov 11We Think HLS Therapeutics (TSE:HLS) Has A Fair Chunk Of Debt
Sep 14HLS Therapeutics (TSE:HLS) Is Due To Pay A Dividend Of $0.05
Aug 15HLS Therapeutics (TSE:HLS) Is Due To Pay A Dividend Of $0.05
Jul 14HLS Therapeutics (TSE:HLS) Has Announced A Dividend Of CA$0.05
Jun 23HLS Therapeutics' (TSE:HLS) Dividend Will Be CA$0.05
Jun 08HLS Therapeutics' (TSE:HLS) Dividend Will Be CA$0.05
May 25HLS Therapeutics' (TSE:HLS) Dividend Will Be CA$0.05
May 10Time To Worry? Analysts Are Downgrading Their HLS Therapeutics Inc. (TSE:HLS) Outlook
Apr 30HLS Therapeutics (TSE:HLS) Has Affirmed Its Dividend Of CA$0.05
Apr 15HLS Therapeutics (TSE:HLS) Has Re-Affirmed Its Dividend Of CA$0.05
Mar 26HLS Therapeutics Inc. (TSE:HLS) Analysts Just Slashed This Year's Estimates
Mar 22HLS Therapeutics (TSE:HLS) Will Pay A Dividend Of CA$0.05
Nov 29HLS Therapeutics (TSE:HLS) Has Affirmed Its Dividend Of CA$0.05
Aug 10CEO報酬分析
| 日付 | 総報酬 | 給与 | 会社業績 |
|---|---|---|---|
| Mar 31 2024 | n/a | n/a | -US$28m |
| Dec 31 2023 | US$1m | US$381k | -US$28m |
報酬と市場: Craigの 総報酬 ($USD 1.41M ) は、 Canadian市場 ($USD 175.38K ) の同規模の企業の平均を上回っています。
報酬と収益: Craigの報酬と会社の業績を比較するにはデータが不十分です。
CEO（最高経営責任者
Craig Millian (56 yo)
1.1yrs
在職期間
US$1,414,327
報酬
Mr. Craig Stuart Millian, MBA, is Chief Executive Officer and Director of HLS Therapeutics Inc. from May 1, 2023. He served as Chief Operating Officer at Corbus Pharmaceuticals Holdings, Inc. since Septemb...
リーダーシップ・チーム
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| CEO & Director | 1.1yrs | US$1.41m | 0.039% $ 42.0k | |
| Interim CFO & Non-Independent Director | less than a year | US$110.39k | 0.013% $ 13.4k | |
| Vice President of Scientific Affairs | 10yrs | US$313.47k | 0.16% $ 167.0k | |
| Senior VP of Legal | 6.1yrs | US$418.09k | 0.0016% $ 1.7k | |
| Senior Vice President of Commercial | less than a year | US$437.71k | 0.0038% $ 4.0k | |
| VP & Corporate Controller | 6.4yrs | データなし | データなし |
3.6yrs
平均在職期間
56yo
平均年齢
経験豊富な経営陣: HLSの経営陣は 経験豊富 であると考えられます ( 3.6年の平均在職年数)。
取締役
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| CEO & Director | 1.1yrs | US$1.41m | 0.039% $ 42.0k | |
| Interim CFO & Non-Independent Director | less than a year | US$110.39k | 0.013% $ 13.4k | |
| Independent Director | 5.3yrs | US$221.56k | データなし | |
| Independent Chairman of the Board | 3yrs | US$248.89k | 0.31% $ 325.9k | |
| Independent Director | 6.3yrs | US$220.00k | データなし | |
| Independent Director | 3yrs | US$207.50k | 0.0016% $ 1.7k | |
| Independent Director | 1.6yrs | US$209.50k | 0.0056% $ 5.9k | |
| Independent Director | less than a year | US$112.49k | データなし |
2.3yrs
平均在職期間
57.5yo
平均年齢
経験豊富なボード: HLSの 取締役会 は 経験豊富 ではない ( 2.3年の平均在任期間) ため、新しい取締役会が必要であると考えられます。